colchicine has been researched along with Obesity in 26 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (23.08) | 18.7374 |
| 1990's | 4 (15.38) | 18.2507 |
| 2000's | 3 (11.54) | 29.6817 |
| 2010's | 8 (30.77) | 24.3611 |
| 2020's | 5 (19.23) | 2.80 |
| Authors | Studies |
|---|---|
| Babyak, A; Biancotto, A; Brady, SM; Chivukula, KK; Dagur, PK; Demidowich, AP; Fantoni, G; Han, JM; Levine, JA; Miller, E; Patel, TP; Periwal, V; Remaley, AT; Sarrafan-Chaharsoughi, Z; Wolska, A; Yanovski, JA | 1 |
| Chen, P; Chen, X; Ding, S; Guo, Z; Li, Q; Lu, Q; Lv, Z | 1 |
| Arner, BE; Biancotto, A; Dagur, PK; Demidowich, AP; Elizondo, DM; Famuyiwa, O; Gupta, S; Jain, A; Levine, JA; Lopez-Ocasio, M; McCoy, JP; Patel, TP; Sarrafan-Chaharsoughi, Z; Saxena, A; Yanovski, JA | 1 |
| Chapman, P; Frampton, C; Hamilton, G; Hudson, B; Judd, A; Stamp, LK | 1 |
| Apps, R; Chen, J; Cheung, FK; Demidowich, AP; Fantoni, G; Levine, JA; Patel, TP; Yanovski, JA | 1 |
| Clebak, KT; Croad, JR; Morrison, A | 1 |
| Brady, SM; Broadney, MM; Chen, KY; Demidowich, AP; Khan, SM; Levine, JA; Onyekaba, GI; Yanovski, JA | 1 |
| Grant, K; Khanna, G; Morris, H; White, AJ | 1 |
| Chang, SJ; Hsieh, MC; Kuo, MC | 1 |
| Davis, AI; Dedhia, N; Demidowich, AP; Yanovski, JA | 1 |
| Anastasiadou, K; Eugenidis, N; Gavalas, E; Giouleme, O; Katsinelos, P; Kountouras, J; Nikolaidis, N; Polyzos, SA; Stefanidis, E; Tzathas, C; Zeglinas, C | 1 |
| Frydrychowicz, C; Mueller, W; Pasieka, B; Petros, S; Pierer, M; Weidhase, L | 1 |
| Shmerling, RH | 1 |
| Chang, GQ; Davydova, Z; Leibowitz, SF; Wortley, KE | 1 |
| Hedley-Whyte, ET; Soto, O | 1 |
| Mertz, DP | 1 |
| Fetissov, S; Nicolaïdis, S | 1 |
| Dube, MG; Kalra, PS; Kalra, SP; Xu, B | 1 |
| Choi, S; Dallman, MF | 1 |
| Choi, S; Clay, M; Dallman, MF; Sparks, R | 1 |
| Dube, MG; Kalra, PS; Kalra, SP; Pu, S | 1 |
| Heidelmann, G; Thiele, P | 1 |
| Christophe, J; Dehaye, J; Winand, J | 1 |
| Klotz, H; Prohaska, E; Salmhofer, H; Schmid, L | 1 |
| Faloon, WW; Rubert, M; Rubulis, A | 1 |
| Drenick, EJ | 1 |
2 review(s) available for colchicine and Obesity
| Article | Year |
|---|---|
Gout: Rapid Evidence Review.
Topics: Adrenal Cortex Hormones; Allopurinol; Colchicine; Febuxostat; Gout; Gout Suppressants; Humans; Obesity; Risk Factors; Sex Factors; Uric Acid | 2020 |
[Therapy of gout].
Topics: Arteriosclerosis; Colchicine; Diabetes Mellitus; Diet; Gout; Humans; Hyperlipidemias; Kidney Calculi; Obesity; Uric Acid | 1977 |
4 trial(s) available for colchicine and Obesity
| Article | Year |
|---|---|
Effects of colchicine on lipolysis and adipose tissue inflammation in adults with obesity and metabolic syndrome.
Topics: Adipose Tissue; Adult; Biomarkers; Colchicine; Humans; Inflammation; Insulin; Insulin Resistance; Lipolysis; Metabolic Syndrome; Obesity | 2022 |
Immunomodulatory effects of colchicine on peripheral blood mononuclear cell subpopulations in human obesity: Data from a randomized controlled trial.
Topics: Adult; Colchicine; Fatty Acid-Binding Proteins; Humans; Inflammation; Leukocytes, Mononuclear; Obesity | 2023 |
Colchicine's effects on metabolic and inflammatory molecules in adults with obesity and metabolic syndrome: results from a pilot randomized controlled trial.
Topics: Adult; Anti-Inflammatory Agents; Betacoronavirus; C-Reactive Protein; Colchicine; Coronavirus Infections; COVID-19; Double-Blind Method; Female; Humans; Interleukin-6; Male; Metabolic Syndrome; Middle Aged; Obesity; Pandemics; Pilot Projects; Pneumonia, Viral; SARS-CoV-2; Treatment Outcome; Young Adult | 2020 |
Effects of colchicine in adults with metabolic syndrome: A pilot randomized controlled trial.
Topics: Adult; Anti-Inflammatory Agents; Blood Glucose; C-Reactive Protein; Colchicine; Female; Humans; Insulin; Insulin Resistance; Male; Metabolic Syndrome; Middle Aged; Obesity; Pilot Projects | 2019 |
20 other study(ies) available for colchicine and Obesity
| Article | Year |
|---|---|
Colchicine prevents ventricular arrhythmias vulnerability in diet-induced obesity rats.
Topics: Animals; Arrhythmias, Cardiac; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Colchicine; Diet, High-Fat; Fibrosis; Male; Obesity; Rats; Ryanodine Receptor Calcium Release Channel; Ventricular Remodeling | 2022 |
The challenges of managing gout in primary care: Results of a best-practice audit.
Topics: Aged; Allopurinol; Clinical Audit; Clinical Chemistry Tests; Clinical Protocols; Colchicine; Comorbidity; Diabetes Mellitus; Disease Management; Female; Gout; Gout Suppressants; Guideline Adherence; Humans; Hyperlipidemias; Hypertension; Hyperuricemia; Male; Mass Screening; Middle Aged; New Zealand; Obesity; Patient Education as Topic; Practice Guidelines as Topic; Primary Health Care; Referral and Consultation; Renal Insufficiency, Chronic; Rheumatology; Rural Population; Uric Acid | 2019 |
Gout in a 15-year-old boy with juvenile idiopathic arthritis: a case study.
Topics: Adolescent; Allopurinol; Ankle Joint; Arthritis, Gouty; Arthritis, Juvenile; Colchicine; Delayed Diagnosis; Diagnosis, Differential; Gout Suppressants; Humans; Magnetic Resonance Imaging; Male; Obesity; Orthopedic Procedures; Osteochondritis Dissecans; Severity of Illness Index; Time-to-Treatment; Treatment Failure; Uric Acid | 2014 |
Colchicine Significantly Reduces Incident Cancer in Gout Male Patients: A 12-Year Cohort Study.
Topics: Adult; Case-Control Studies; Cohort Studies; Colchicine; Gout; Gout Suppressants; Humans; Hyperlipidemias; Hypertension; Incidence; Male; Middle Aged; Neoplasms; Obesity; Proportional Hazards Models; Risk Factors; Taiwan | 2015 |
Colchicine to decrease NLRP3-activated inflammation and improve obesity-related metabolic dysregulation.
Topics: Adipose Tissue; Animals; Colchicine; Diabetes Mellitus, Type 2; Gout Suppressants; Humans; Immunity, Innate; Inflammasomes; Inflammation; Insulin Resistance; Macrophages; Metabolic Diseases; Mice; NLR Family, Pyrin Domain-Containing 3 Protein; Obesity; Risk Factors | 2016 |
Colchicine to decrease inflammation and fibrosis in patients with metabolic dysregulation.
Topics: Animals; Anti-Inflammatory Agents; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Colchicine; Fibrosis; Humans; Inflammation; Metabolic Syndrome; Models, Theoretical; Obesity; T-Lymphocytes, Cytotoxic | 2016 |
Colchicine triggered severe rhabdomyolysis after long-term low-dose simvastatin therapy: a case report.
Topics: Acute Kidney Injury; Aged; Colchicine; Ezetimibe; Gout Suppressants; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Male; Obesity; Rhabdomyolysis; Simvastatin; Treatment Outcome | 2017 |
Management of gout: a 57-year-old man with a history of podagra, hyperuricemia, and mild renal insufficiency.
Topics: Adrenal Cortex Hormones; Anti-Inflammatory Agents, Non-Steroidal; Arthritis, Gouty; Colchicine; Gout; Gout Suppressants; Humans; Hyperuricemia; Incidence; Male; Middle Aged; Obesity; Renal Insufficiency; Risk Factors; Toes; Uric Acid | 2012 |
Peptides that regulate food intake: orexin gene expression is increased during states of hypertriglyceridemia.
Topics: Animals; Blood Glucose; Body Weight; Carrier Proteins; Colchicine; Dietary Fats; Galanin; Gene Expression Regulation; Hypertriglyceridemia; Hypothalamus; Insulin; Intracellular Signaling Peptides and Proteins; Leptin; Male; Mice; Mice, Inbred Strains; Neuropeptides; Obesity; Orexins; Rats; Rats, Sprague-Dawley; RNA, Messenger; Triglycerides | 2003 |
Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 33-2003. A 37-year-old man with a history of alcohol and drug abuse and sudden onset of leg weakness.
Topics: Adult; Alcoholism; Arthritis, Gouty; Biopsy; Colchicine; Diagnosis, Differential; Gout Suppressants; Humans; Hypertension; Leg; Male; Muscle Weakness; Muscle, Skeletal; N-Methyl-3,4-methylenedioxyamphetamine; Neuromuscular Diseases; Obesity; Substance-Related Disorders | 2003 |
[Gout as a joint disease and as a generalized disease. Incidence, diagnosis and therapy].
Topics: Allopurinol; Colchicine; Diabetes Complications; Gout; Humans; Hypertension; Indomethacin; Kidney Diseases; Obesity; Proteinuria; Socioeconomic Factors; Synovial Fluid; Uric Acid; Urinary Calculi | 1980 |
Neuropeptide Y in the magnocellular hypothalamic neurons of obese Zucker rats.
Topics: Animals; Colchicine; Hypothalamus; Immunohistochemistry; Male; Neurons; Neuropeptide Y; Neurosecretory Systems; Obesity; Paraventricular Hypothalamic Nucleus; Rats; Rats, Zucker; Supraoptic Nucleus; Tissue Distribution | 1998 |
Increased receptor sensitivity to neuropeptide Y in the hypothalamus may underlie transient hyperphagia and body weight gain.
Topics: Animals; Appetite Stimulants; Behavior, Animal; Binding, Competitive; Colchicine; Darkness; Dose-Response Relationship, Drug; Eating; Hyperphagia; Hypothalamus; Injections, Intraventricular; Light; Male; Neuropeptide Y; Obesity; Peptides, Cyclic; Rats; Rats, Sprague-Dawley; Receptors, Neuropeptide Y; RNA, Messenger; Signal Transduction; Ventromedial Hypothalamic Nucleus; Weight Gain | 1997 |
Hypothalamic obesity: multiple routes mediated by loss of function in medial cell groups.
Topics: Animals; Arcuate Nucleus of Hypothalamus; Colchicine; Dorsomedial Hypothalamic Nucleus; Eating; Energy Metabolism; Hypothalamic Diseases; Injections; Insulin; Leptin; Male; Obesity; Paraventricular Hypothalamic Nucleus; Proteins; Rats; Rats, Sprague-Dawley; Ventromedial Hypothalamic Nucleus | 1999 |
Rats with hypothalamic obesity are insensitive to central leptin injections.
Topics: Animals; Body Weight; Colchicine; Dorsomedial Hypothalamic Nucleus; Eating; Hypothalamic Diseases; Injections, Intraventricular; Leptin; Male; Obesity; Proteins; Rats; Rats, Sprague-Dawley; Ventromedial Hypothalamic Nucleus | 1999 |
Melanocortin signaling is decreased during neurotoxin-induced transient hyperphagia and increased body-weight gain.
Topics: Agouti-Related Protein; alpha-MSH; Animals; Colchicine; Hyperphagia; Intercellular Signaling Peptides and Proteins; Male; Microinjections; Neurotoxins; Obesity; Pro-Opiomelanocortin; Proteins; Rats; Rats, Sprague-Dawley; RNA, Messenger; Ventromedial Hypothalamic Nucleus; Weight Gain | 2000 |
[The effect of colchicine, heavy water and cytochalasin B on adipose tissue metabolism in normal and obese, hyperglycemic mice].
Topics: Acetates; Adipose Tissue; Animals; Carbon Radioisotopes; Colchicine; Cytochalasin B; Glucose; Hyperglycemia; Male; Mice; Obesity; Tritium; Water | 1973 |
[Gout from the view of a special hospital for rheumatic patients].
Topics: Acute Disease; Adolescent; Adult; Aged; Austria; Child; Cholesterol; Colchicine; Colic; Diabetes Complications; Diagnosis, Differential; Diagnostic Errors; Gout; Heart Diseases; Hospitals, Special; Humans; Indomethacin; Kidney Diseases; Middle Aged; Obesity; Phenylbutazone; Probenecid; Prognosis; Radiography; Rheumatic Diseases; Sulfinpyrazone; Time Factors; Uric Acid; Uricosuric Agents | 1971 |
Cholesterol lowering, fecal bile acid, and sterol changes during neomycin and colchicine.
Topics: Administration, Oral; Anticholesteremic Agents; Bile Acids and Salts; Cholesterol; Colchicine; Feces; Gastrointestinal Diseases; Humans; Neomycin; Obesity; Sterols | 1970 |
Hyperuricemia, acute gout, renal insufficiency and urate nephrolithiasis due to starvation.
Topics: Blood; Colchicine; Diet, Reducing; Fasting; Gout; Humans; Kidney Calculi; Kidney Diseases; Obesity; Starvation; Uric Acid; Urine | 1965 |